Research Article

A Proposed Approach for Joint Modeling of the Longitudinal and Time-To-Event Data in Heterogeneous Populations: An Application to HIV/AIDS’s Disease

Table 4

Comparison of the results for the three approaches on HIV/AIDS patients.

Parameter name PA SA JLCM
EstimatesSE valueEstimatesSE valueEstimatesSE value

Class 1Longitudinal submodel
Intercept0.6260.054<0.0010.6120.052<0.0011.0570.134<0.001
Time−0.0110.002<0.001−0.0060.0020.002−0.0070.002<0.001
Treatment (ddC)0.0290.0180.1060.02820.0180.124−0.0160.0390.681
Hgb0.0080.0040.0480.0070.0040.049−0.0010.0070.815
Survival submodel
Treatment (ddC)0.0550.1200.6460.1510.1700.373−0.2590.9550.785
Hgb0.0340.0250.1740.0061.0060.8480.3080.0960.001
−0.5080.644<0.001−0.4800.296<0.001---

Class 2Longitudinal submodel
Intercept1.1630.086<0.0011.1520.086<0.0010.7080.098<0.001
Time−0.0060.0020.003−0.0040.0020.055−0.0110.002<0.001
Treatment (ddC)0.0210.0220.3450.0220.0220.3290.0040.0280.877
Hgb−0.0180.005<0.001−0.0180.0050.001−0.0020.0060.709
Survival submodel
Treatment (ddC)−0.7620.221<0.001−0.7630.3210.017−0.5580.2630.034
Hgb0.0590.0590.3170.0310.0820.702−0.0060.0600.917
−0.4880.719<0.001−0.4300.494<0.001---

JLCM: joint latent class models; PA: proposed approach; SA: separate approach; SE: standard error; Hgb: baseline hemoglobin values; ddC: Zalcitabine treatment.